NDC product
MILNACIPRAN HYDROCHLORIDE
NDC 31722-847 · Camber Pharmaceuticals, Inc.
Key facts
| Product NDC | 31722-847 |
|---|---|
| Proprietary name | MILNACIPRAN HYDROCHLORIDE |
| Nonproprietary name | MILNACIPRAN HYDROCHLORIDE |
| Substances | MILNACIPRAN HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Camber Pharmaceuticals, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA205147 |
| Pharmacologic classes | Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
| Marketing start | Mar 19, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: